Ohr Pharmaceutical Inc OHRP Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

15:53 EST 14 Nov 2017 | BioPortfolio Reports


Ohr Pharmaceutical Inc Ohr, formerly BBM Holdings Inc is a novel therapy developing company that offers biopharmaceutical and development of novel therapeutics and delivery technologies for the treatment of ocular diseases. The company offers products which include squalamine, trodusquemine and SKS technology products. Its squalamine products are used in wet agerelated macular degeneration, retinal vein occlusion, proliferative diabetic retinopathy and diabetic macular edema indications. Ohr offers squalamine eye drops that is developed as noninvasive solution to treat wet form of agerelated macular degeneration. The company's KSK technology products provide treatment for glaucoma, steroid induced glaucoma, eye allergy and retinal disease. It operates research facilities in San Diego. Ohr is headquartered in New York, the US.

Ohr Pharmaceutical Inc Key Recent Developments

Aug 08,2017: Ohr Pharmaceutical Announces Fiscal Third Quarter 2017 Earnings

May 11,2017: Ohr Pharmaceutical Announces Appointment of Hon. Mike Ferguson as Chairman of the Board of Directors

May 11,2017: Ohr Pharmaceutical Announces Fiscal Second Quarter 2017 Earnings

Feb 14,2017: Ohr Pharmaceutical Announces Strategic Update and Fiscal First Quarter 2017 Earnings

Dec 22,2016: Ohr Pharmaceutical Reports Fiscal Year 2016 Financial and Business Results

This comprehensive SWOT profile of Ohr Pharmaceutical Inc provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Ohr Pharmaceutical Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.

The profile contains critical company information including*,

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Original Article: Ohr Pharmaceutical Inc OHRP Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300


More From BioPortfolio on "Ohr Pharmaceutical Inc OHRP Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300"

Quick Search


Relevant Topic

Diabetes is a lifelong condition that causes a person's blood sugar level to become too high. The two main types of diabetes are: type 1 diabetes type 2 diabetes In the UK, diabetes affects approximately 2.9 million people. There are a...